{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:16:08Z","timestamp":1760645768729},"reference-count":0,"publisher":"Informa UK Limited","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMR"],"DOI":"10.2147\/cmr.s6765","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T01:08:04Z","timestamp":1284685684000},"page":"131","source":"Crossref","is-referenced-by-count":6,"title":["Review of (90)Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin’s lymphoma"],"prefix":"10.2147","author":[{"given":"Christos","family":"Emmanouilides","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,10]]},"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T01:08:19Z","timestamp":1284685699000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/review-of-90y-ibritumomab-tiuxetan-as-first-line-consolidation-radio-i-peer-reviewed-article-CMR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/cmr.s6765","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}